Radiofrequency ablation
Using heat generated by radio waves to destroy tumour tissue.
What it is
Radiofrequency ablation (RFA) is a minimally invasive procedure that uses heat generated by radiofrequency waves to destroy cancer cells. It is used to treat various types of cancers, including liver, lung, kidney, and thyroid cancers, as well as benign tumors such as uterine fibroids and osteoid osteoma.
What research shows
Studies suggest that RFA is effective in treating small tumors, with high local control rates and low recurrence rates. Evidence indicates that RFA can be safely performed in selected patients, with minimal complications. However, more research is needed to determine the optimal patient selection and technique.
Current status
RFA is a viable treatment option for selected patients with small tumors, but its use is limited by the size and location of the tumor. Further research is needed to improve patient selection and technique.
Moderate evidenceKey studies
- PMID 42530948PubMed ↗
Transarterial chemoembolization plus thermal ablation improved clinical outcomes compared with chemoembolization alone in patients with liver-confined unresectable hepatocellular carcinoma.
- PMID 42521911PubMed ↗
Clinical and imaging factors associated with prolonged ablation time in radiofrequency ablation for early-stage breast cancer were investigated, but no specific findings were reported.
- PMID 42521644PubMed ↗
Image-guided thermal ablation is a safe and effective primary treatment for small renal mass and localized renal cell carcinoma ≤ 4 cm.
- PMID 42512276PubMed ↗
Selective intra-arterial lipiodol injection (SIALI) technique was described as a method to improve lesion conspicuity on conventional imaging for percutaneous thermal ablation of hypervascular liver tumors.
This information is provided for general education only and is not medical advice. Medical procedures carry individual risks and benefits. Always consult a qualified healthcare professional before making decisions about your treatment.